DOI : 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 06 · Volume 45 · September 2012 DOI: 10.1055/s-002-23649

Abstracts of the Xth Congress of the Interdisciplinary TDM Task Force of the AGNP together with the Swiss Society for Pharmacovigilance in Psychiatry (SGAMSP) and the Swiss-Austrian Chapter of the International Society of Pharmacovigilance (ISoP)
Psychotropic Drugs: Risks and Risk Management
Psychiatric Clinic Königsfelden, Brugg, Switzerland, 26th–28th September 2012

Chair: Eveline Jaquenoud Sirot, Psychiatric Clinic Königsfelden, Brugg, Switzerland
Abstracts (HTML) Autorenliste
A1
Babl, M; Wenzel-Seifert, K; Haen, E: Age- and sex-dependency of psychotropic drug induced hyperprolactinemia
A2
Bangratz, S; Moyses, M; Mader, S; Huemer, J; Koubek, D; Laczkovics, C; Merl, E; Karwautz, A: Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
A3
Ben-Omar, N; Jahner, T; Melchner, D; Haen, E: Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
A4
Ben-Omar, N; Wenzel-Seifert, K; Haen, E: Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
A5
Brandl, R; Köber, R; Jahner, T; Outlaw, EM; Wenzel-Seifert, K; Wittmann, K; Haen, E: Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
A6
Fric, M; Laux, G: Therapeutic drug monitoring (TDM) of serotonergic antidepressants in anxiety and obsessive-compulsive disorders
A7
Hahn, M; Roll, SC: Increasing drug therapy safety in psychiatry: implementing a pharmacist on the ward
A8
Hansen, D; Taurines, R; Wewetzer, C; Pfuhlmann, B; Plener, P; Mehler-Wex, C; Gerlach, M; Egberts, K: Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
A9
Hefner, G; Fellgiebel, A; Hiemke, C: Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients
A10
Jaquenoud Sirot, E; Harenberg, S; Vandel, P; Mendonça Lima, CA; Perrenoud, P; Kemmerling, K; Zullino, DF; Hilleret, H; Crettol, S; Jonzier-Perey, M; Powell Golay, K; Brocard, M; Eap, CB; Baumann, P: Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
A11
Jaquenoud Sirot, E; Stephan, PL; Eap, CB; van der Velden, JW; Baumann, P: Matched case-control study: therapeutic drug monitoring in pharmacovigilance
A12
Köppl, A; Melchner, D; Haen, E: Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
A13
Kulpok, C; Taurines, R; Wewetzer, C; Pfuhlmann, B; Plener, P; Mehler-Wex, C; Gerlach, M; Egberts, K: Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
A14
Laib, K; Brünen, S; Pfeifer, P; Vincent, P; Hiemke, C: Therapeutic drug monitoring of bupropion for depression
A15
Lay, C; Spisla, C: Rabbit syndrome and akathisia in a patient treated with risperidone
A16
Onuoha, MR; Haen, E: The frequency and cost comparison of haloperidol prescriptions – haloperidol data analysis from therapeutic drug monitoring 2006–2011
A17
Ostad Haji, E; Mann, K; Dragicevic, A; Müller, MJ; Boland, K; Rao, ML; Fric, M; Laux, G; Hiemke, C: Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
A18
Paulzen, M; Frergsen, N; Veselinovic, T; Ostad Haji, E; Hiemke, C; Gründer, G: Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
A19
Paulzen, M; Henkel, K; Tauber, S; Reich, A; Eap, CB; Gründer, G: Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
A20
Schäfer, A; Hiemke, C; Baumann, P: Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011
A21
Schmidt, FM; Lichtblau, N; Uribe, MM; Kirchherr, H; Himmerich, H: Agomelatine in breast milk
A22
Schultze, I; Hiemke, C; Eusterschulte, B: Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs
A23
Spisla, C; Jaquenoud Sirot, E: An unusual case of abuse of nasal drops
A24
Stegmann, B; Wenzel-Seifert, K; Dörfelt, A; Haen, W: Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
A25
Suter, K; Waldner-Knogler, K; Stephan, PL; Jaquenoud Sirot, E: Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)
A26
Unterecker, S; Riederer, P; Deckert, J; Pfuhlmann, B: Interaction of valproic acid and antidepressant drugs
A27
Wolf, M; Köpp, A; Dörfelt, A; Haen, E: Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
A28
Zorina, OL; Haueis, P; Greil, W; Grohmann, R; Kullak-Ublick, GA; Russmann, S: Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients